Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4–8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011–12 and 2012–13

Prevalence of HIV-1 drug resistance amongst newly diagnosed HIV-infected infants age 4–8 weeks, enrolled in three nationally representative PMTCT effectiveness surveys, South Africa: 2010, 2011–12 and 2012–13

Abstract Background South Africa (SA) has expanded efforts to reduce mother-to-child transmission of HIV (MTCT) to less than 2% at six weeks after birth and to less than 5% at 18 months postpartum by 2016. Despite improved antiretroviral regimens and coverage between 2001 and 2016, there is little d...

Full description

Bibliographic Details
Main Authors: Gillian M. Hunt, Johanna Ledwaba, Anna Salimo, Monalisa Kalimashe, Thu-Ha Dinh, Debra Jackson, Gayle Sherman, Adrian Puren, Nobubelo K. Ngandu, Carl Lombard, Lynn Morris, Ameena Goga
Format: Article
Language:English
Published: BMC 2019-09-01
Series:BMC Infectious Diseases
Subjects:
HIV drug resistance genotyping
Dried blood spots
Children
Online Access:http://link.springer.com/article/10.1186/s12879-019-4339-y

Internet

http://link.springer.com/article/10.1186/s12879-019-4339-y

Similar Items